Medical Textile Market Global Report 2026

The medical textile market size has grown exponentially in recent years. It will grow from $19.44 billion in 2025 to $24.75 billion in 2026 at a compound annual growth rate (CAGR) of 27.4%. The growth in the historic period can be attributed to increasing prevalence of hospital acquired infections, rising healthcare infrastructure development, growth in surgical procedures across healthcare facilities, increasing demand for hygiene and protective products, expansion of healthcare expenditure globally.

The medical textile market size is expected to see exponential growth in the next few years. It will grow to $64.28 billion in 2030 at a compound annual growth rate (CAGR) of 26.9%. The growth in the forecast period can be attributed to rising investment in advanced healthcare materials, increasing demand for personalized healthcare solutions, growing adoption of sustainable medical textile materials, expanding elderly population and chronic disease burden, increasing technological advancements in implantable textile products. Major trends in the forecast period include increasing demand for infection prevention and control products, rising adoption of antimicrobial medical textiles, growing use of biodegradable and biocompatible textile materials, increasing demand for advanced wound care products, expanding use of high performance surgical and implantable textiles.

The increasing prevalence of chronic diseases is expected to propel the growth of the medical textiles market going forward. Chronic diseases are long-term medical conditions that generally develop gradually, persist over extended periods, and often require continuous management or treatment to control symptoms and reduce complications. The growing prevalence of chronic diseases is attributed to unhealthy lifestyle behaviors, which increase the demand for long-term healthcare, early diagnosis, and advanced treatment solutions. Medical textiles support patients with chronic diseases by improving comfort, facilitating continuous care, and enhancing treatment outcomes through applications such as wound care, compression therapy, implantable materials, and wearable health-monitoring technologies. For instance, in July 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, chronic conditions were responsible for an estimated 4.4 million years of healthy life lost among Australians in 2023, accounting for 85% of the country’s total disease burden. Therefore, the increasing prevalence of chronic diseases is driving the growth of the medical textiles market.

Major companies operating in the medical textiles market are focusing on strengthening innovation capabilities through specialized biomedical textile laboratories to accelerate product development, enhance material performance, and support customized healthcare solutions. Biomedical textile innovation labs are specialized research and development facilities established to create advanced textile-based medical materials and technologies for surgical, implantable, and therapeutic applications. For instance, in February 2026, Corza Medical, a US-based medical technology company, launched its Biomedical Textiles Innovation Lab to accelerate OEM product development within the healthcare industry. The facility focuses on advanced biomedical textile engineering, rapid prototyping, material evaluation, and collaborative product development for medical device manufacturers. The innovation lab is intended to support the creation of next-generation textile-based medical products with improved performance, greater customization, and faster time-to-market.

In December 2025, Nextil, a Spain-based textile manufacturing and apparel solutions company, entered into an agreement to acquire a 51% stake in Isavela for an undisclosed amount. Through this acquisition, Nextil aimed to strengthen its position in the United States medical textiles market, expand its portfolio in the high-value medical garments segment, and integrate the value chain from fabric development to finished medical apparel. Isavela is a US-based medical textile company specializing in compression and post-operative garments for the healthcare sector, providing premium textile solutions to hospitals, clinics, and healthcare professionals.

Major companies operating in the medical textile market are 3M Company; Medline Industries; Cardinal Health; Medtronic; DuPont; Smith & Nephew; Kimberly-Clark Corporation; Mölnlycke Health Care; Freudenberg Group; Asahi Kasei Corporation; Paul Hartmann AG; Berry Global; BSN medical; Hollister Incorporated; Winner Medical; Ahlstrom; ATEX Technologies; Bally Ribbon Mills; Precision Fabrics Group; medi GmbH & Co. KG; Trelleborg AB; Shawmut Corporation; Indorama Corporation; Eastex Products; PurThread Technologies; Muller Textiles; Shanghai Leheng Equipment Co. Ltd.

North America was the largest region in the medical textile in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical textile market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical textile market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical textile market consists of sales of implantable textiles, non-implantable textiles, healthcare and hygiene textiles, extracorporeal devices, surgical textiles, wound care textiles, orthopedic textiles, protective medical apparel, sanitary products, smart medical textiles, and hospital furnishing textiles. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The medical textile market research report is one of a series of new reports that provides medical textile market statistics, including medical textile industry global market size, regional shares, competitors with a medical textile market share, detailed medical textile market segments, market trends and opportunities, and any further data you may need to thrive in the medical textile industry. This medical textile market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.